Funders › NY › National Cancer Center Inc › 2023
Grants paid by National Cancer Center Inc, tax year 2023
EIN 13-1919715 · West Islip, NY · Form 990, Schedule I · NTEE G30Z
In tax year 2023, National Cancer Center Inc (EIN 13-1919715) reported 20 grants paid totaling $1,536,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Nyu Langone Health New York, NY | A | $200,000 | paid | Target copy number alternations | 202540769349300029 |
| 2023 | Nyu Langone Health New York, NY | A | $200,000 | paid | TARGET COPY NUMBER ALTERNATIONS | 202440589349300434 |
| 2023 | Cleveland Clinic Cleveland, OH | A | $102,000 | paid | PKN1-SRF ENE RE: PROSTRATE CANCER | 202440589349300434 |
| 2023 | Cleveland Clinic Cleveland, OH | A | $102,000 | paid | PKN-SRF ENE re:Prostate Cancer | 202540769349300029 |
| 2023 | Nyu School of Medicine New York, NY | A | $102,000 | paid | Therapeutic targeting stem cells | 202540769349300029 |
| 2023 | Nyu School of Medicine New York, NY | A | $102,000 | paid | THERAPEUTIC TARGETING STEM CELLS | 202440589349300434 |
| 2023 | Nyu Medical Center New York, NY | A | $52,000 | paid | TARGETING MELANOMA PLASTICITY | 202440589349300434 |
| 2023 | U of Nebraska Medical Center Omaha, NE | A | $52,000 | paid | NTSR1 RADIOTHERAPY COLORCTAL CANCER | 202440589349300434 |
| 2023 | Uc San Francisco Med School San Francisco, CA | A | $52,000 | paid | Synthetic control T Cell infiltration | 202540769349300029 |
| 2023 | Nyu Medical Center New York, NY | A | $52,000 | paid | Targeting melanoma plasticity | 202540769349300029 |
| 2023 | Dana-Farber Cancer Institute Boston, MA | A | $52,000 | paid | Decipher USP7 NI Ewing Sarcoma | 202540769349300029 |
| 2023 | U C Sanfrancisco Med School San Francisco, CA | A | $52,000 | paid | SYNTHETICCONTORL TCELL INFILTRATION | 202440589349300434 |
| 2023 | Baylor College of Medicine Houston, TX | A | $52,000 | paid | Role & Regulation of Hippo pathwayi | 202540769349300029 |
| 2023 | Univ of Pittsburgh School Med Pittsburgh, PA | A | $52,000 | paid | IMPROVE TUMOR SUPPRESSING W/ MYOSIN | 202440589349300434 |
| 2023 | John Hopkins Medical School Baltimore, MD | A | $52,000 | paid | Intratumoral Hypoxia Study | 202540769349300029 |
| 2023 | Baylor College of Medicine Houston, TX | A | $52,000 | paid | ROLE ®ULATION OF HIPPOPATHWAYI | 202440589349300434 |
| 2023 | Johns Hopkins Medical School Baltimore, MD | A | $52,000 | paid | INTRATUMORAL HYPOXIA STUDY | 202440589349300434 |
| 2023 | Dana-Farber Cancer Institute Boston, MA | A | $52,000 | paid | DECIPHER USP7 NI EWING SARCOMA | 202440589349300434 |
| 2023 | University of Pittsburgh School Med Pittsburgh, PA | A | $52,000 | paid | Improve tumor suppressing W/ Myosin | 202540769349300029 |
| 2023 | U of Nebraska Medical Center Omaha, NE | A | $52,000 | paid | NTSR1 Radiotherapy colorectal cancer | 202540769349300029 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.